We leverage this capability to distinguish basal from estrogen receptor (ER) positive (ER +) breast tumor samples, not only achieving high classification accuracy but also identifying the genes and pathways that segregate the cancer subtypes. The gene discussed is ESR1; the disease is breast neoplasm.